Fraser W D, Logue F C, MacRitchie K, Wilson R M, Gray H W, Beastall G H, O'Reilly D S
Institute of Biochemistry, Royal Infirmary Glasgow, Scotland.
Acta Endocrinol (Copenh). 1991 Jun;124(6):652-7. doi: 10.1530/acta.0.1240652.
In 35 thyrotoxic patients and 35 patients receiving thyroxine replacement therapy mean serum intact parathyroid hormone concentrations were lower than in euthyroid normal volunteer controls. In 20 hypothyroid patients intact PTH was increased relative to euthyroid controls. Mean serum adjusted calcium was increased in thyrotoxic patients relative to euthyroid controls and in 8 toxic patients with elevated serum adjusted calcium (greater than 2.60 mmol/l) intact PTH was below the assay detection limit (less than 0.5 pmol/l). Indices of PTH activity were consistent with intact PTH measurements in thyrotoxic patients with nephrogenous cyclic adenosine monophosphate lower, tubular maximum reabsorption of phosphate higher, and urinary calcium creatinine ratio higher than controls. In hypothyroid patients these indices of PTH activity suggest relative end organ resistance to PTH with nephrogenous cyclic adenosine monophosphate similar, tubular maximum reabsorption of phosphate similar, and calcium creatinine ratio lower than in controls. In treated hypothyroid patients nephrogenous cyclic adenosine monophosphate was higher, tubular maximum reabsorption of phosphate similar, and calcium creatinine ratio higher than in controls. These results are compatible with the hypothesis that thyroid status modifies the renal responses to PTH (1-84).
在35例甲状腺毒症患者和35例接受甲状腺素替代治疗的患者中,血清完整甲状旁腺激素的平均浓度低于甲状腺功能正常的志愿者对照组。在20例甲状腺功能减退患者中,与甲状腺功能正常的对照组相比,完整甲状旁腺激素升高。与甲状腺功能正常的对照组相比,甲状腺毒症患者的平均血清校正钙升高,并且在8例血清校正钙升高(大于2.60 mmol/L)的甲状腺毒症患者中,完整甲状旁腺激素低于检测限(小于0.5 pmol/L)。甲状旁腺激素活性指标与甲状腺毒症患者的完整甲状旁腺激素测量结果一致,其中肾源性环磷酸腺苷较低、肾小管对磷的最大重吸收较高以及尿钙肌酐比值高于对照组。在甲状腺功能减退患者中,这些甲状旁腺激素活性指标提示对甲状旁腺激素存在相对终末器官抵抗,肾源性环磷酸腺苷相似、肾小管对磷的最大重吸收相似,且钙肌酐比值低于对照组。在接受治疗的甲状腺功能减退患者中,肾源性环磷酸腺苷较高、肾小管对磷的最大重吸收相似,且钙肌酐比值高于对照组。这些结果与甲状腺状态改变肾脏对甲状旁腺激素(1-84)反应的假说相符。